- Home
- WIX vs BHC Comparison
WIX vs BHC Comparison
Compare WIX & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WIX | BHC |
|---|---|---|
| Founded | 2006 | N/A |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2013 | 1996 |
Fundamental Metrics
Financial Performance| Metric | WIX | BHC |
|---|---|---|
| Price | $80.11 | $6.25 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 22 | 3 |
| Target Price | ★ $134.67 | $8.00 |
| AVG Volume (30 Days) | 1.5M | ★ 4.8M |
| Earning Date | 05-13-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,724,000,000.00 |
| Revenue This Year | $15.80 | $4.61 |
| Revenue Next Year | $13.21 | N/A |
| P/E Ratio | $28.86 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $40.00 | $4.33 |
| 52 Week High | $190.92 | $8.69 |
Technical Indicators
Market Signals| Indicator | WIX | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 75.07 | 61.29 |
| Support Level | $75.00 | $5.42 |
| Resistance Level | $81.44 | $7.40 |
| Average True Range (ATR) | 5.11 | 0.45 |
| MACD | 1.75 | 0.06 |
| Stochastic Oscillator | 99.76 | 62.91 |
Price Performance
Historical ComparisonAbout WIX Wix.com Ltd.
Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years, it has invested heavily and introduced its Wix Studio offering for partners, which are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.